PBYI Chart
- 52-Week Range: $1.64 - $11.60
- Market Capitalization: $89.95M
- Short Percentage: 0%
- Target Price: $6.40
- Shares Outstanding: 44.97M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
PBYI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial ResultsBusiness Wire | April 21st
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire | April 5th
- Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 3rd
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire | February 3rd
- Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual MeetingBusiness Wire | December 10th
- Puma Biotech's Neratinib Fails To Extend Overall Survival In Brain Cancer TrialBenzinga | November 22nd
- Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual MeetingBusiness Wire | November 20th
- Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS)Business Wire | November 19th
Company Info
Website: https://www.pumabiotechnology.com
Address: 10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
Sector: Healthcare
Industry: Biotechnology
Full time employees: 196
Address: 10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
Sector: Healthcare
Industry: Biotechnology
Full time employees: 196
$PBYI finally a pullback
$PBYI make it rain
let’s see some green
$PBYI Let’s get it
$PBYI buy more doomers!!!
$PBYI only getting stronger
$PBYI we back boys
$PBYI buy the dip…smfh
$PBYI bear trap dude
$PBYI fake wall lets break it
$PBYI the end is near